Navigation Links
The First Annual Cervical Cancer/HPV Conference Tackles Controversial Vaccine Issues and Encourages Advocacy
Date:9/22/2007

uer, M.D. MPH, California Department of Public Health and of the California STD/HIV Prevention Training center included:

-- Currently, there are more than 20 million people infected with a

genital HPV infection in the U.S.

-- There are 6.2 million new HPV infections annually, with more than 80

percent of people (men and women) acquiring the infection at some point

in their lives

-- Sixty percent of girls will contract the HPV infection by the time they

are 16 years of age or within 4 years of sexual debut.

-- Of the girls infected, 2/3 will clear the infection within 2 years

without intervention, although 10 percent will not be able to clear

infection at all and will go on to develop high-risk HPV or cervical

cancer

-- HPV is considered the "common cold" of STIs

-- Strains 16 and 18 account for more than 70 percent of HPV infections

-- Type 16 is responsible for more than half of all cervical cancers,

which Cervarix (GlaxoSmithKline) and Gardasil (Merck) are designed to

specifically target

Attending the conference were women, their families and friends from across the United States, all of whom have been affected in some way by HPV and/or cervical cancer, whether survivors or those seeking additional information. The main goal for the conference was to educate these women and provide them with the tools and information they need to become advocates for HPV and cervical cancer prevention within their own communities.

Inspiring a sisterhood among attendees, the women also focused on the stigma attached to having this specific type of cancer, especially since it is related to a sexually transmitted infection. Many women were made to feel shamed or dirty when they were diagnosed with HPV, even though it is the most common sexually transmitted infection. Many women addressed the fact that when they received their diagnosis of cervical can
'/>"/>

SOURCE National Cervical Cancer Coalition
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
3. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
4. Ablynx Announces Interim Results of First Nanobody Phase I Study of ALX-0081 (ANTI-VWF)
5. Advanced Life Sciences Announces Supplemental Efficacy Data from First Pivotal Phase 3 Pneumonia Clinical Trial
6. Advanced Life Sciences to Host Conference Call to Discuss Data From Cethromycins First of Two Phase 3 Pneumonia Trials
7. First Phase II Short-Term Study on Dapagliflozin Shows Results on Safety, Tolerability and Glycemic Markers in Subjects With Type 2 Diabetes
8. Advanced Cell Technology Develops First Human Embryonic Stem Cell Line without Destroying an Embryo
9. First Demonstration of nanoImmunology: a Nanomaterials-based Therapeutic Approach to Treat Allergy
10. First single breast cancer study to show significant survival benefit for women switching from tamoxifen to Arimidex
11. Mymetics HIV Vaccine Demonstrates First-Ever Production of Neutralizing IgA Antibodies in Non-Human Primate Model
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/8/2008)...ency of Poly-ICR as Vaccine Adjuvant, SAN DIEGO, ...euticals,Corporation (TSX: NVN) today presented po...prietary Toll-like Receptor 3 agonist, Poly IC-Pol...ss 2008 in Lyon, France.,Study results demonstrate...ng the Toll-like Receptor 3 (TLR3) pathway. Data s...
(Date:10/8/2008)... clinical improvement in patients with pulmonary ...atment options have limited benefit for this debil...ood vessel disease, -- Imatinib mesylate, avail...ancers, known to inhibit protein associated with P... imatinib mesylate in PAH in 2009 EAST HANOV...
(Date:10/7/2008)...wswire/ -- McLaren Health Care and its Great,Lakes...s leading medical,minds to share the latest work u...tinal cancer treatments. The October 11th symposiu...Laren,s Sukamal Saha, M.D., an,award-winning surgi... for,colorectal cancer has gained worldwide recogn...
(Date:10/7/2008)...ewswire/ -- The Texas Cardiac Arrhythmia,Institute...ected as one of,only a few sites in the nation to ...a new device to treat persistent atrial fibrillati... research center specializing in heart,rhythm diso...l Center and,Texas Cardiovascular Consultants., "...
Breaking Medicine Technology:Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 2Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 3Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 4Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 5Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 2Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 3Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 4Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 5Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 6Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 7Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 8Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 9Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 10Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 11Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 12News Media Advisory: World's Leading Surgical Oncologists to Gather at McLaren Regional Medical Center to Present Latest Work on Breast, Gastrointestinal Cancer Treatments 2Texas Cardiac Arrhythmia Institute at St. David's Medical Center Selected to Conduct Clinical Trial for Device to Treat Atrial Fibrillation 2Nationwide Survey Reports that Mothers View Cleaning Homes and Toys as Essential to Preventing Colds 26 Flu 916 1Nationwide Survey Reports that Mothers View Cleaning Homes and Toys as Essential to Preventing Colds 26 Flu 916 2Nationwide Survey Reports that Mothers View Cleaning Homes and Toys as Essential to Preventing Colds 26 Flu 916 3BIO key 28R 29 and Tiger IT Awarded a Follow on Contract for Nationwide Voter Citizen Registration in Bangladesh 1341 1BIO key 28R 29 and Tiger IT Awarded a Follow on Contract for Nationwide Voter Citizen Registration in Bangladesh 1341 2BIO key 28R 29 and Tiger IT Awarded a Follow on Contract for Nationwide Voter Citizen Registration in Bangladesh 1341 3BIO key 28R 29 and Tiger IT Awarded a Follow on Contract for Nationwide Voter Citizen Registration in Bangladesh 1341 4New study highlights stigma and stress of living with HIV AIDS in Serbia 6945 1New study highlights stigma and stress of living with HIV AIDS in Serbia 6945 2New study highlights stigma and stress of living with HIV AIDS in Serbia 6945 3UF botanists 3A Flowering plants evolved very quickly into 5 groups 1338 1UF botanists 3A Flowering plants evolved very quickly into 5 groups 1338 2UF botanists 3A Flowering plants evolved very quickly into 5 groups 1338 3
(Date:10/10/2008)... BEDFORD, Mass., Oct. 10 /PRNewswire-FirstCall/...loper, manufacturer and supplier of premium,diagno...ts dedicated to,serving the healthcare needs of wo...uarter and fiscal 2008 operating results on Tuesda...ction with the release, management will,host a con...
(Date:10/10/2008)... PARK CITY, Utah, Oct. 10 /PRNewswire/ -- NuVie... management of Trace Life Sciences Inc.,(Trace), i...cyclotron,production facilities in Denton, Texas. ... Indium-111, Iodine-123 and Thallium-201 used in,m... NuView Chairman and,CEO, stated that "We are conf...
(Date:10/10/2008)... Coach Holly Warlick Teams Up with Legal and Me...rst-Ever Cancer and Careers Seminar in,Knoxville, ...gnition of National,Breast Cancer Awareness Month,... have joined forces with YWCA Knoxville, The Welln...ocate Holly Warlick, University of Tennessee,women...
(Date:10/10/2008)... The Healthcare Technolog...Care , Exton, PA (PRWEB) ...Valley Chapters of the national Healthcare Informa...ned forces to bring regional health information te...onal conference entitled The Healthcare Technology...
Breaking Medicine News(10 mins):Health News:Hologic, Inc. To Release Fourth Quarter and Fiscal 2008 Operating Results on Tuesday, November 11, 2008 2Health News:Local Experts Help Women Living and Working with Cancer Even the Score 2Health News:Local Experts Help Women Living and Working with Cancer Even the Score 3Health News:Local Experts Help Women Living and Working with Cancer Even the Score 4Health News:HIMSS New Jersey and Delaware Valley Chapters Sponsor Regional Conference 2
...test mysteries that has been plaguing mankind is t... have finally been able to unravel the mystery wit...y scientists after a study of more than 1000 peopl...eed to be answered on a scale of 1 to 10 and the s...
...by researchers in the Institute of Preventive Medi...asionally may be beneficial in countering dementia...that people who drank wine weekly or monthly were ...ia, said that the findings are important because t...
...earchers of the Harvard Medical School, of more th...amine antagonists, i.e. anti-psychotics, for eithe... have an increased risk of breast cancer. The stud... taking dopamine antagonists and 55,000 women who ...
...ished in an online issue of Nature Medicine by res... a stunning discovery of a bold new type of vaccin...gs. The study which was carried// out on monkeys s...med and adapted in humans may signal a major new t...
Other Medicine News:Health News:The Happiness Formula.... 2
Flattened Blunt Tip, Angled; 13mm from angle to tip; 3mm "U" shape tip; overall length excluding hub 28mm; in stainless steel.
Set of Five, Long, with side port; all approximately 75mm in length; in Stainless Steel.
HYDRACLEAR is our brandname for a remarkable moisture rich element that lies throughout the interior and exterior of the ACUVUE ADVANCE Brand Contact Lenses creating a unique soft, silky feel.
The only solution for in-line digital measurement
Medicine Products: